PK Study for Endostar Continuous Intravenous Infusion in NSCLC Patients With 1st-line Platinum Based Chemotherapy
Clinical trial NCT04942301 · UNKNOWN
Trial details
- NCT number
- NCT04942301
- Sponsor
- Jiangsu Simcere Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-30
- Primary completion
- 2021-12-25
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.